Pediatrics

Pfizer asks FDA to OK COVID-19 vaccine for under 5s

Pfizer Inc. said Wednesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of its COVID-19 vaccine in children younger than the age of 5 years.

Diseases, Conditions, Syndromes

Repeat infections with COVID-19 may become the norm

COVID-19 might be easing into a new status as a widely circulating and somewhat harsher version of the common cold, experts say—a virus that folks could contract repeatedly, even if they were recently infected.

page 2 from 7